High-dose-rate brachytherapy in the treatment of uterine cervix cancer. Analysis of dose effectiveness and late complications

International Journal of Radiation Oncology Biology Physics

Volumn 50, Issue 5, 2001, Pages 1123-1135

  Ferrigno, Robson ^a   Dos Santos Novaes, Paulo Eduardo Ribeiro ^a   Pellizzon, Antonio Cássio Assis ^a   Maia, Maria Aparecida Conte ^a   Fogarolli, Ricardo César ^a   Gentil, André Cavalcanti ^a   Salvajoli, João Victor ^a  

^a A C CAMARGO CANCER CENTER   (Brazil)

Author keywords

Cervix cancer; High dose rate brachytherapy; Radiotherapy

Indexed keywords

BIOLOGICAL ORGANS; RADIOTHERAPY; STATISTICAL METHODS; TUMORS;

BRACHYTHERAPY;

BIOMEDICAL ENGINEERING;

ADULT; AGE; AGED; ARTICLE; BEAM THERAPY; BLADDER; BRACHYTHERAPY; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; HUMAN; INTESTINE OBSTRUCTION; INTESTINE PERFORATION; MAJOR CLINICAL STUDY; METASTASIS; PELVIS; PRIORITY JOURNAL; RADIATION DOSE; RADIATION DOSE FRACTIONATION; RADIATION INJURY; RADIATION RESPONSE; RECTUM; RECTUM FISTULA; RECTUM HEMORRHAGE; SMALL INTESTINE; TIME; TREATMENT FAILURE; UTERINE CERVIX CARCINOMA;

ACTUARIAL ANALYSIS; BRACHYTHERAPY; CARCINOMA; DOSE FRACTIONATION; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; FOLLOW-UP STUDIES; HEALTH SURVEYS; HUMANS; INTESTINE, SMALL; LIFE TABLES; MIDDLE AGED; NEOPLASM METASTASIS; PARTICLE ACCELERATORS; PELVIS; QUESTIONNAIRES; RADIATION INJURIES; RADIOISOTOPE TELETHERAPY; RADIOTHERAPY DOSAGE; RECTUM; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TIME FACTORS; TREATMENT OUTCOME; URINARY BLADDER; UTERINE CERVICAL NEOPLASMS;

EID: 0035424763     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(01)01533-4     Document Type: Article

References (68)

1. The American Brachytherapy Society survey of brachytherapy practice for carcinoma of the cervix in the United States
2. Literature analysis of high dose rate brachytherapy fractionation schedules in the treatment of cervical cancer: Is there an optimal fractionation schedule?
3. Resource utilization: High dose rate versus low dose rate brachytherapy for gynecologic cancer
4. Patient preference for high- or low-dose-rate brachytherapy in carcinoma of the cervix
5. Staging of gynecologic cancer; cervical and vulva
6. Brief summary of radiobiological principles in fractionated radiotherapy
7. Non-parametric estimations from complete observations
8. Regression models and life table
9. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC)
10. High-dose-rate brachytherapy for carcinoma of the cervix: High tech or high risk?
11. The American Brachytherapy Society recommendations for high-dose-rate brachytherapy for carcinoma of the cervix
12. The patterns of care outcome study for cancer of the uterine cervix. Results of the Second National Practice Survey
13. Radiation therapy alone in the treatment of carcinoma of the uterine cervix: A 20-year experience
14. Carcinoma of the cervix, stage III: Results of radiation therapy
15. Patterns of care outcome studies: Results of the national practice in cancer of the cervix
16. Carcinoma of the intact uterine cervix treated with radiotherapy alone: A French Cooperative Study: Update and multivariate analysis of prognostic factors
17. Annual report on the results of treatment in gynaecological cancer
18. High dose rate brachytherapy for carcinoma of the cervix
19. High-dose-rate afterloading brachytherapy in carcinoma of the cervix. An experience of 1992 patients
20. Radiation therapy alone in the treatment of carcinoma of the uterine cervix. Analysis of tumor recurrence
21. Treatment results and prognostic factors in inoperable carcinoma of the cervix treated with external plus high dose brachytherpy
22. Long term results of definitive radiotherapy for cervical carcinoma using four applications of high dose rate afterloading
23. High dose rate brachytherapy practice for the treatment of gynaecological cancers in the UK
24. High dose rate brachytherapy in the treatment of cervical carcinoma
25. Prognostic factors in patients with carcinoma of the uterine cervix treated with external beam irradiation and IR-192 high-dose-rate brachytherapy
26. High and low dose-rate brachytherapy for cervical carcinoma
27. Definitive radiotherapy combined with high-dose-rate brachytherapy for stage III carcinoma of the uterine cervix: Retrospective analysis of prognostic factors concerning patient characteristics and treatment parameters
28. High-dose-rate intracavitary brachytherapy (HDR-IC) in treatment of cervical carcinoma. 5-Year results and implication of increased low-grade rectal complication on initiation of an HDR-IC fractionation scheme
29. The effect of treatment duration in the local control of cervix cancer
30. The influence of treatment time on outcome for squamous cell cancer of the uterine cervix
31. Carcinoma of the uterine cervix: Impact of prolongation of treatment time and timing of brachytherapy on outcome of radiation therapy
32. Effect of total treatment time on event-free survival in carcinoma of the cervix
33. Combined low-dose-rate brachytherapy and external beam radiation for cervical cancer: Experience over ten years
34. Overall treatment time in advanced cervical carcinomas. A critical parameters in treatment outcome
35. High-dose rate intracavitary irradiation for carcinoma of the uterine cervix. The adverse effect of treatment prolongation
36. High-dose-rate versus low-dose-rate brachytherapy in the treatment of cervical cancer. Analysis of tumor recurrence. The University of Wisconsin experience
37. Invasive cervical carcinoma in young women
38. The influence of patient age and tumor grade on the prognosis of carcinoma of the cervix
39. Analysis of multiple prognostic factors in patients with stage IB cervical cancer: Age as a major determinant
40. Young age as a prognostic factor in cervical cancer. Analysis of population based on data from 10,022 cases
41. Cervical cancer survival in Nijmegan region, The Netherlands 1970 to 1985
42. Youth as a prognostic factors in carcinoma of the uterine cervix: A matched analysis
43. Treatment results of high dose rate brachytherapy in patients with carcinoma of the cervix
44. Carcinoma of the cervix: Analysis of complications after primary external beam radiation and Ir-192 HDR brachytherapy
45. The risk of determining risk with multivariable models
46. Pretreatment and treatment factors associated with improved outcome in squamous cell carcinoma of the uterine cervix: A final report of the 1973 and 1978 Patterns of Care Studies
47. The prediction of late rectal complications in patients treated with high dose-rate brachytherapy for carcinoma of the cervix
48. Late rectal complications following high dose rate intracavitary brachytherapy in cancer of the cervix
49. The prediction of late rectal complictions and rectal dose following high dose rate intracavitary radiotherapy in patients with uterine cervix cancer: In vivo dosimetric analysis
50. Complications of therapy for cervical cancer
51. Bladder or rectal injury following radiotherapy for cervical cancer
52. Hemorrhagic cystitis following radiotherapy for stage IB cancer of the cervix
53. A simple method of obtaining equivalent doses for use in HDR brachytherapy
54. A CT-compatible version of the Fletcher system intracavitary applicator: Clinical application and 3-dimensional treatment planning
55. High dose rate brachytherapy for carcinoma of the cervix: Risk factors for late rectal complications
56. Dosimetry for intracavitary placements for uterine and cervical carcinoma: Results of orthogonal film, TLD, and CT assisted techniques
57. Bladder and rectal dose of gynecologic high-dose rate implants: Comparison of orthogonal radiographic measurements with in vivo and CT-assisted measurements
58. Influence of age, prior abdominal surgery, fraction size, and dose on complications after radiation therapy for squamous cell cancer of the uterine cervix
59. Impact of dose in outcome of irradiation alone in carcinoma of the uterine cervix: Analysis of two different methods
60. Twice-daily fractionation of external irradiation with brachytherapy in bulky carcinoma of the cervix. Phase I/II study of the Radiation Therapy Oncology Group 88-05
61. Figo IIIB squamous cell carcinoma of the cervix: An analysis of prognostic factors emphasizing the balance between external beam and intracavitary radiation therapy
62. Complications in 831 patients with squamous cell carcinoma of the intact uterine cervix treated with 3000 rads or more whole pelvis irradiation
63. Analysis of the servere complications of irradiation of carcinoma of the cervix: Whole pelvis irradiation and intracavitary radium
64. A report of late rectosigmoid morbidity in patients with advanced cancer of the cervix, treated with a 6-week pelvic brick technique
65. An analysis of the severe complications of irradiation of carcinoma of the uterine cervix: Treatment with intracavitary radium and parametrial irradiation
66. Radiation therapy morbidity in carcinoma of the uterine cervix: Dosimetric and clinical correlation